95 related articles for article (PubMed ID: 7571222)
1. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
Oesterling JE; Moyad MA; Wright GL; Beck GR
Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
[TBL] [Abstract][Full Text] [Related]
2. The variation of percent free prostate-specific antigen determined by two different assays.
Yang CR; Ou YC; Horng YY; Lee HS
Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171
[TBL] [Abstract][Full Text] [Related]
3. Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.
Jacobsen SJ; Klee GG; Lilja H; Wright GL; Oesterling JE
Urology; 1995 Mar; 45(3):447-53. PubMed ID: 7533456
[TBL] [Abstract][Full Text] [Related]
4. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers.
Prestigiacomo AF; Stamey TA
J Urol; 1996 Jun; 155(6):1977-80. PubMed ID: 8618301
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
Schambeck CM
Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
[TBL] [Abstract][Full Text] [Related]
6. Assay standardization bias: different prostate cancer detection rates and clinical outcomes resulting from different assays for free and total prostate-specific antigen.
Sotelo RJ; Mora KE; Pérez LH; Novoa J; Carmona O; De Andrade R; Borges RE; Parada D; Loeb S; Catalona WJ
Urology; 2007 Jun; 69(6):1143-6. PubMed ID: 17572203
[TBL] [Abstract][Full Text] [Related]
7. Reliability analysis of first and second generation PSA assays.
Wymenga LF; Groenier K; Visser-van Brummen P; Marrink J; Mensink HJ
Can J Urol; 2000 Aug; 7(4):1070-6. PubMed ID: 11109077
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
[TBL] [Abstract][Full Text] [Related]
9. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3 investigational assays for the free form of prostate specific antigen.
Nixon RG; Meyer GE; Blase AB; Gold MH; Brawer MK
J Urol; 1998 Aug; 160(2):420-5. PubMed ID: 9679890
[TBL] [Abstract][Full Text] [Related]
11. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.
Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE
Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236
[TBL] [Abstract][Full Text] [Related]
12. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG
Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
[TBL] [Abstract][Full Text] [Related]
13. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
Wener MH; Daum PR; Brawer MK
Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
[TBL] [Abstract][Full Text] [Related]
14. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.
Nixon RG; Lilly JD; Liedtke RJ; Batjer JD
Arch Pathol Lab Med; 1997 Apr; 121(4):385-91. PubMed ID: 9140308
[TBL] [Abstract][Full Text] [Related]
15. A comparison of three free and total PSA assays.
Roth HJ; Stewart SC; Brawer MK
Prostate Cancer Prostatic Dis; 1998 Dec; 1(6):326-331. PubMed ID: 12496875
[TBL] [Abstract][Full Text] [Related]
16. Production, analysis, and characterization of reference materials for prostate-specific antigen.
Garg UC; Howanitz JH; Nakamura RM; Plous RH; Eckfeldt JH
Arch Pathol Lab Med; 1995 Dec; 119(12):1104-8. PubMed ID: 7503657
[TBL] [Abstract][Full Text] [Related]
17. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay.
Schild SE; Wong WW; Novicki DE; Ferrigni RG; Swanson SK
Urology; 1996 Jun; 47(6):878-81. PubMed ID: 8677580
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
19. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.
Klee GG; Dodge LA; Zincke H; Oesterling JE
J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749
[TBL] [Abstract][Full Text] [Related]
20. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
